Skip to main content
Premium Trial:

Request an Annual Quote

Roche, St. Luke s Health System Establish Molecular Diagnostics Center in Kansas City

NEW YORK, Dec. 9 (GenomeWeb News) - Saint Luke's Health System, a Kansas City-based provider of molecular diagnostics and clinical testing, said today that it has signed a five-year strategic alliance agreement with Roche Diagnostics to establish a Molecular Center of Excellence to perform molecular diagnostic testing using Roche's PCR technology and other genomic technologies.

Financial terms of the agreement were not provided.

According to Saint Luke's Health System, molecular diagnostic testing will improve its diagnostic services "by providing more sensitive, more specific, and faster results so that patient treatment can be improved." Molecular testing should be able to measure the amount of a pathogen present in the system, allowing better treatment options, and will also provide accurate negative-predictive values when screening for genetic mutations in cystic fibrosis and other diseases, Saint Luke's said.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.